P688: VIRTUAL SCREENING PROTOCOL TO IDENTIFY TYROSINE KINASE INHIBITORS WITH A POTENTIAL TO INTERACT WITH P‐GLYCOPROTEIN AND TO ACT AS MDR CHEMOSENSITIZERS: A VALIDATION STUDY.

MLA

Beleva, E., et al. “P688: Virtual Screening Protocol to Identify Tyrosine Kinase Inhibitors with a Potential to Interact with P‐Glycoprotein and to Act as Mdr Chemosensitizers: A Validation Study.” HemaSphere, vol. 6, June 2022, pp. 584–85. EBSCOhost, https://doi.org/10.1097/01.HS9.0000845636.31864.5d.

APA

Beleva, E., Tsakovska, I., Alov, P., Pencheva, T., Lessigiarska, I., & Pajeva, I. (2022). P688: Virtual Screening Protocol to Identify Tyrosine Kinase Inhibitors with a Potential to Interact with P‐Glycoprotein and to Act as Mdr Chemosensitizers: A Validation Study. HemaSphere, 6, 584–585. https://doi.org/10.1097/01.HS9.0000845636.31864.5d

Chicago

Beleva, E., I. Tsakovska, P. Alov, T. Pencheva, I. Lessigiarska, and I. Pajeva. 2022. “P688: Virtual Screening Protocol to Identify Tyrosine Kinase Inhibitors with a Potential to Interact with P‐Glycoprotein and to Act as Mdr Chemosensitizers: A Validation Study.” HemaSphere 6 (June): 584–85. doi:10.1097/01.HS9.0000845636.31864.5d.